Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 20150263)

1.

Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab.

Ribas A, Benz MR, Allen-Auerbach MS, Radu C, Chmielowski B, Seja E, Williams JL, Gomez-Navarro J, McCarthy T, Czernin J.

J Nucl Med. 2010 Mar;51(3):340-6. doi: 10.2967/jnumed.109.070946. Epub 2010 Feb 11.

2.

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH.

J Nucl Med. 2005 Jun;46(6):945-52.

3.

Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.

Yue J, Chen L, Cabrera AR, Sun X, Zhao S, Zheng F, Han A, Zheng J, Teng X, Ma L, Ma Y, Han D, Zhao X, Mu D, Yu J, Li Y.

J Nucl Med. 2010 Apr;51(4):528-34. doi: 10.2967/jnumed.109.072124. Epub 2010 Mar 17.

4.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
5.

Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.

Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA.

Chest. 2006 Feb;129(2):393-401.

PMID:
16478857
6.

[Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].

Liu X, Zhou NK, Zhang JM, Liang ZY, Zheng X.

Ai Zheng. 2006 Dec;25(12):1512-6. Chinese.

PMID:
17166377
7.

A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.

Herrmann K, Buck AK, Schuster T, Rudelius M, Wester HJ, Graf N, Scheuerer C, Peschel C, Schwaiger M, Dechow T, Keller U.

J Nucl Med. 2011 Dec;52(12):1898-902. doi: 10.2967/jnumed.111.094698. Epub 2011 Nov 7.

8.

Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.

Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):846-51. doi: 10.1007/s00259-012-2061-8. Epub 2012 Jan 26.

PMID:
22278320
9.

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, Mattfeldt T, Neumaier B, Reske SN, Hetzel M.

J Nucl Med. 2003 Sep;44(9):1426-31.

10.

Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.

Wang H, Zhang J, Tian J, Qu B, Li T, Chen Y, Liu J, Wang S.

J Nucl Med. 2009 Nov;50(11):1857-64. doi: 10.2967/jnumed.109.064238. Epub 2009 Oct 16. Erratum in: J Nucl Med. 2010 Jan;51(1):167.

11.

Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.

Han D, Yu J, Yu Y, Zhang G, Zhong X, Lu J, Yin Y, Fu Z, Mu D, Zhang B, He W, Huo Z, Liu X, Kong L, Zhao S, Sun X.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1235-41. doi: 10.1016/j.ijrobp.2009.07.1681. Epub 2009 Nov 10.

PMID:
19910143
12.

18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.

Yamane T, Takaoka A, Kita M, Imai Y, Senda M.

Ann Nucl Med. 2012 Jul;26(6):478-84. doi: 10.1007/s12149-012-0597-0. Epub 2012 Apr 3.

PMID:
22477262
13.

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH.

Mol Imaging Biol. 2006 Jan-Feb;8(1):36-42.

PMID:
16362149
14.

Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.

Yang W, Zhang Y, Fu Z, Yu J, Sun X, Mu D, Han A.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1291-9. doi: 10.1007/s00259-010-1412-6. Epub 2010 Mar 23.

PMID:
20309686
15.

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.

Herrmann K, Ott K, Buck AK, Lordick F, Wilhelm D, Souvatzoglou M, Becker K, Schuster T, Wester HJ, Siewert JR, Schwaiger M, Krause BJ.

J Nucl Med. 2007 Dec;48(12):1945-50. Epub 2007 Nov 15.

16.

Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.

Yamamoto Y, Nishiyama Y, Kimura N, Ishikawa S, Okuda M, Bandoh S, Kanaji N, Asakura M, Ohkawa M.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):236-45. Epub 2007 Oct 2.

PMID:
17909790
17.

Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.

Lu L, Jiang L, Guan H, Gao Y, Lu H.

Hell J Nucl Med. 2012 Sep-Dec;15(3):206-9. doi: 10.1967/s002449910056. Epub 2012 Oct 25.

PMID:
23106052
18.

Anti-CTLA4 antibody therapy related complications on FDG PET/CT.

Koo PJ, Klingensmith WC, Lewis KD, Bagrosky BM, Gonzalez R.

Clin Nucl Med. 2014 Jan;39(1):e93-6. doi: 10.1097/RLU.0b013e318292a775.

PMID:
23657138
19.

Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

Kahraman D, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Holstein A, Dietlein M, Wolf J, Kobe C.

J Nucl Med. 2011 Dec;52(12):1871-7. doi: 10.2967/jnumed.111.094458. Epub 2011 Nov 7.

20.

Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.

Tripathi M, Sharma R, D'Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A.

Clin Nucl Med. 2009 Dec;34(12):878-83. doi: 10.1097/RLU.0b013e3181becfe0.

PMID:
20139821
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk